AI Summary & Key Takeaways
AI InsightLTBI screening, includingrisk factor assessment and TST/QuantiFERON-TB testing, is necessary in the early diagnostic workup for TB in LT recipients.
📌 3 Key Takeaways
Abstract
Background/aim: Solid organ transplant (SOT) recipients have increased risk of tuberculosis (TB). We aimed to investigate theprevalence and features of TB in liver transplant (LT) recipients at our transplantation canter.Materials and methods: All patients who underwent LT between January 2004 and December 2013 and whose data were accessiblewere included in the study. Demographic features, tuberculin skin test (TST) results, and TB prevalence were recorded. Characteristicsof LT recipients who developed TB were evaluated.Results: A total of 403 patients underwent LT during this period. Mean age was 47.27 ± 11.04 years; 280 (69.47%) were males. The TSTwas administered to 108 (25.91%) and the QuantiFERON-TB test to 1 patient. TST positivity was determined in 28 (25.93%). LatentTB infection (LTBI) treatment was not recommended to any of the LT candidates. In the posttransplant period, 5 patients (1.24%)developed TB over a median duration of 14 (min: 7, max: 84) months, 2 of whom were found to have had LTBI in the pretransplantperiod.Conclusion: The prevalence of TB in LT recipients at our center was similar to that in the current literature. LTBI screening, includingrisk factor assessment and TST/QuantiFERON-TB testing, is necessary in the early diagnostic workup for TB in LT recipients.